修复时机对钝性胸主动脉损伤行胸主动脉腔内修复术后死亡率的影响
基于主动脉创伤基金会前瞻性多中心注册研究2015至2022年数据,分析222例Grade 2和3级钝性胸主动脉损伤行胸主动脉腔内修复术患者,早期修复组179例(81%)。多因素回归显示低血红蛋白、高损伤严重度评分和Grade 3级损伤与30天死亡率相关(P < 0.05),而修复时机与30天死亡率无关。作者认为经选择的患者延迟胸主动脉腔内修复术或可行,需进一步研究。
要点
- 222例Grade 2和3级钝性胸主动脉损伤行胸主动脉腔内修复术,早期修复组179例(81%)。
- 30天院内死亡14例(6%),其中2例为主动脉相关死亡。
- 多因素回归显示低血红蛋白、高损伤严重度评分和Grade 3级损伤与30天死亡率相关(P < 0.05),修复时机与之无关。
核心结论
- 作者认为,经选择的Grade 2和3级钝性胸主动脉损伤患者延迟行胸主动脉腔内修复术或可行,需进一步研究以识别其他预测成功的因素。
研究设计与样本
- 主动脉创伤基金会前瞻性多中心注册研究2015至2022年纳入的Grade 2和3级钝性胸主动脉损伤患者,按修复时机分为早期修复(< 24小时)和晚期修复(> 24小时)两组。
主要发现
- 共分析222例Grade 2和3级钝性胸主动脉损伤行胸主动脉腔内修复术患者,早期修复组179例(81%)。
- 两组在损伤严重度评分、格拉斯哥昏迷评分、年龄和性别方面无差异;早期修复组更可能有纵隔增宽和左锁骨下动脉至损伤距离更短。
- 30天院内死亡14例(6%),其中2例为主动脉相关死亡。
- 30天死亡率与冠状动脉疾病/外周血管疾病/既往心脏血运重建基线发生率较高、收缩压较低、格拉斯哥昏迷评分较低、血红蛋白较低、血小板计数较低、血pH较低以及入院时乳酸和损伤严重度评分较高相关。
- 多因素回归分析显示,低血红蛋白、高损伤严重度评分和Grade 3级钝性胸主动脉损伤与30天死亡率相关(P < 0.05),而胸主动脉腔内修复术时间与之无关。
关键数值与推荐
- 早期修复定义为< 24小时,晚期修复定义为> 24小时。
临床怎么用
- 作者认为,经选择的Grade 2和3级钝性胸主动脉损伤患者延迟行胸主动脉腔内修复术或可行。
- 原文未据此给出推荐。
局限性
- 作者指出需进一步研究以识别其他预测成功的因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Blunt thoracic aortic injuries (BTAIs) are traditionally treated as emergencies with most fixed within 24 hours of arrival by thoracic endovascular aortic repair (TEVAR) regardless of grade of injury. However, the optimal timing of repair remains debated. METHODS: All patients with Grade 2 and 3 BTAI enrolled in the Aortic Trauma Foundation prospective multicenter registry from 2015 to 2022 were categorized dependent on timing of repair (early repair [ER] < 24 hours, late repair > 24 hours). Chi-square/Fisher's exact tests were used to compare patient/operative factors and logistic regression analysis was performed to identify factors related to 30-day mortality. RESULTS: Two hundred and twenty two Grade 2 and 3 BTAI treated by TEVAR were analyzed, with 179 in the ER group (81%). There was no difference between the groups regarding Injury Severity Score (ISS), Glasgow Coma Scale, age, or gender. Those in ER were more likely to have a widened mediastinum and a shorter distance from the left subclavian artery to the injury. Thirty-day in-hospital mortality occurred in 14 patients (6%), 2 of which were aortic-related. Thirty-day mortality was associated with a higher baseline incidence of coronary artery disease/peripheral vascular disease/previous cardiac revascularization; lower systolic blood pressure, Glasgow Coma Scale, hemoglobin, platelet count, and blood pH; and higher lactate and ISS on arrival. On multivariate regression analysis, lower hemoglobin, higher ISS, and Grade 3 BTAI were associated with 30-day mortality (P < 0.05), although time to TEVAR was not. CONCLUSIONS: In selected patients, delay in performance of TEVAR for Grade 2 and 3 BTAI may be possible. Further research is necessary to identify other factors predictive of success.
引用
- Marquardt C, Bose S, Wittgen C, et al. Effects of Timing of Repair on Mortality Following Thoracic Endovascular Aortic Repair for Blunt Thoracic Aortic Injury. Ann Vasc Surg. 2024. PMID: 39343367. doi:10.1016/j.avsg.2024.07.106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。